Table 2.
Description of patients with COVID-19 with or without obstructive sleep apnoea (OSA) and a comparison between non-hospitalised and hospitalised patients with OSA
| Non-OSA n=407 |
OSA n=38 |
P value | OSA Non-hospitalised n=19 |
OSA hospitalised n=19 | P value | |
| Age (mean in years, SD) | 51.9 (17.5) | 61.3 (12.9) | 5.60×10−4* | 56.3 (11.0) | 66.3 (12.9) | 0.057 |
| Sex (male) (N, %) | 147 (36.1) | 19 (50.0) | 0.645 | 12 (63.2) | 7 (36.8) | 0.776 |
| BMI (mean kg/m2, SD) | 26.71 (5.27) | 31.15 (5.56) | 3.38×10−3* | 30.91 (5.58) | 31.37 (5.77) | 1 |
| Comorbidities or outcomes (N, %) | 118 (29.0) | 24 (63.2) | 1.74×10−4* | 12 (63.2) | 12 (63.2) | 1 |
| Hospitalised (N, %) | 72 (17.7) | 19 (50.0) | 3.21×10−5* |
Differences between non-OSA versus OSA individuals and non-hospitalised patients with OSA versus hospitalised patients with OSA among COVID-19-positive individuals. 7/19 patients with hospitalisation had OSA diagnosis but did not have any other disease comorbidities P values were based on χ2 test. Fisher’s exact test was used if the sample size was ≤5. For continuous variables, we used Student’s t-test. BMI was measured of 264 participants including 239 non-OSA and 25 OSA individuals. Comorbidities and outcomes=hypertension, diabetes, coronary heart disease, asthma, chronic obstructive pulmonary disease.
*Statistically significant.
BMI, body mass index.